vimarsana.com

Latest Breaking News On - Anti infectives - Page 1 : vimarsana.com

Pharma market grows 9 5% in January

The Indian pharmaceutical market (IPM) saw a robust growth of 9.5% in January with all major therapy areas recording double-digit growth. According to market research firm Pharmarack, a majority of the top 10 therapy areas, including cardiac, anti-infectives, and gastrointestinal, showed double-digit value growth. Respiratory, pain/analgesics, urology, antineoplastics, and stomatologicals also saw higher unit growth.

Animal Drug Compounding Market is Predicted to Reach USD

Weak acute drug sales pose risk to Indian pharma s growth tempo

Growth in the Indian pharmaceutical industry slowed to 5.8 percent in August

Recce Pharmaceuticals Granted New Anti-Viral Patent in Australia for RECCE® Anti-Infectives

SYDNEY, Australia, Aug. 04, 2023 (GLOBE NEWSWIRE) Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synthetic anti-infectives, is pleased to announce the Australian Patent Office has formally granted Recce a new family four patent, “Process for Preparation of Biologically Active Copolymer,” with expiry in 2041. “We are thrilled to receive this new family of intellectual property, granted by the Australian Patent Office, with further market monopolies reinfo

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.